Zentalis Pharmaceuticals Inc (ZNTL)
12.06
+0.10
(+0.84%)
USD |
NASDAQ |
May 17, 16:00
12.06
0.00 (0.00%)
After-Hours: 20:00
Zentalis Pharmaceuticals Revenue (Quarterly): 40.56M for March 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 40.56M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
40.56M
Minimum
Mar 2024
40.56M
Maximum
Mar 2024
40.56M
Average
40.56M
Median
Mar 2024
Revenue (Quarterly) Benchmarks
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 10.07M |
| Total Expenses (Quarterly) | 65.32M |
| EPS Diluted (Quarterly) | 0.14 |
| Enterprise Value | 368.15M |
| Profit Margin (Quarterly) | 24.82% |
| Earnings Yield | -27.59% |